US 10988477
GCN2 inhibitors and uses thereof
granted A61PA61P35/00
Quick answer
US patent 10988477 (GCN2 inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00